. | Normal TT . | Normal TT . | P Value . | Low TT . | P Value . | Low TT . | P Value . |
---|---|---|---|---|---|---|---|
Normal cFT . | Low cFT . | Normal cFT . | Low cFT . | ||||
N, % 2641 (79.2%) | 277 (8.3%) | 96 (2.9%) | 320 (9.6%) | ||||
General | |||||||
Age, y | 58.9 (10.7) | 68.4 (9.3) | <.001 | 54.7 (9.2) | <.001 | 63.4 (10.8) | <.001 |
Current smoking, % | 21.7 | 19.3 | .358 | 16.8 | .263 | 18.6 | .211 |
Alcohol (≥5 days/week), % | 23.0 | 22.2 | .760 | 24.0 | .834 | 20.8 | .373 |
Fair or poor general health, % | 30.3 | 50.6 | <.001 | 28.4 | .696 | 44.6 | <.001 |
≥1 comorbidity, % | 60.3 | 79.9 | <.001 | 63.5 | .520 | 80.4 | <.001 |
Hormonal measurements | |||||||
Total T, nmol/liter | 18.4 (5.5) | 14.2 (3.7) | <.001 | 9.6 (0.7) | <.001 | 7.8 (2.5) | <.001 |
Calculated free T, pmol/liter | 325.7 (74.2) | 194.3 (22.7) | <.001 | 246.8 (19.5) | <.001 | 159.8 (55.3) | <.001 |
Total estradiol, pmol/liter | 76.7 (23.6) | 70.1 (25.7) | <.001 | 58.9 (17.6) | <.001 | 54.8 (19.6) | <.001 |
Free estradiol, pmol/liter | 1.3 (0.4) | 1.0 (0.4) | <.001 | 1.2 (0.4) | .040 | 1.0 (0.4) | <.001 |
SHBG, nmol/liter | 43.2 (17.2) | 58.1 (21.9) | <.001 | 18.9 (4.2) | <.001 | 31.6 (15.0) | <.001 |
LH, U/liter | 5.9 (3.0) | 8.8 (6.8) | <.001 | 4.8 (2.2) | .006 | 6.9 (6.8) | <.001 |
TSH, U/liter | 1.7 (1.2) | 1.6 (1.2) | .680 | 1.7 (1.8) | .523 | 1.8 (1.7) | .050 |
Free T4, ng/dL | 1.26 (0.22) | 1.27 (0.23) | .403 | 1.24 (0.24) | .550 | 1.23 (0.24) | .030 |
IGF-1, ng/mL | 134.5 (42.3) | 116.5 (43.3) | <.001 | 152.9 (47.2) | <.001 | 128.3 (57.0) | .015 |
Sexual function | |||||||
Overall sexual function score | 21.8 (6.8) | 17.6 (7.2) | <.001 | 23.1 (5.4) | .087 | 18.9 (7.5) | <.001 |
% men infrequent sexual thoughts | 25.1 | 42.3 | <.001 | 16.1 | .052 | 39.7 | <.001 |
% men erectile dysfunction | 27.0 | 51.0 | <.001 | 18.1 | .059 | 45.2 | <.001 |
% men infrequent morning erections | 35.5 | 64.1 | <.001 | 35.9 | .934 | 51.7 | <.001 |
% men with 3 sexual symptoms | 9.3 | 25.9 | <.001 | 5.5 | .220 | 23.5 | <.001 |
Physical function | |||||||
Time to walk 50 feet, sec | 13.4 (3.2) | 25.0 (5.0) | <.001 | 13.2 (2.6) | .581 | 14.4 (3.3) | <.001 |
SF36 physical function score | 50.7 (7.7) | 46.2 (9.6) | <.001 | 50.9 (7.9) | .845 | 47.6 (8.9) | <.001 |
% men reduced vigorous activity | 21.9 | 41.7 | <.001 | 19.2 | .529 | 38.6 | <.001 |
% men impairment in walking 1 km | 2.5 | 7.0 | <.001 | 3.2 | .678 | 7.0 | <.001 |
% men impairment in bending | 5.2 | 13.8 | <.001 | 2.1 | .199 | 12.0 | <.001 |
Psychological function | |||||||
Beck depression inventory score | 6.7 (6.4) | 8.1 (7.0) | .001 | 6.0 (5.7) | .262 | 7.8 (6.7) | .005 |
% men with sadness | 4.0 | 5.4 | .238 | 3.2 | .697 | 6.0 | .083 |
% men with loss of energy | 5.3 | 9.5 | .005 | 0 | 7.9 | .059 | |
% men with fatigue | 4.9 | 8.7 | .009 | 4.2 | .747 | 9.2 | .002 |
Biochemical measurements | |||||||
Hemoglobin, g/liter | 150.1 (10.7) | 146.4 (10.9) | <.001 | 148.7 (9.4) | .243 | 146.2 (13.0) | <.001 |
hs-CRP, mg/liter | 0.39 (0.66) | 0.61 (1.11) | <.001 | 0.63 (0.94) | .016 | 0.77 (1.52) | <.001 |
Glucose, mmol/liter | 5.5 (1.2) | 6.0 (2.0) | <.001 | 6.0 (1.6) | <.001 | 6.2 (2.0) | <.001 |
HOMA-IR | 2.9 (3.4) | 4.3 (6.1) | <.001 | 4.4 (3.3) | <.001 | 5.5 (6.7) | <.001 |
Body composition parameters | |||||||
Waist circumference, cm | 97.1 (10.4) | 99.9 (11.7) | <.001 | 105.4 (9.5) | <.001 | 106.5 (12.1) | <.001 |
Weight, kg | 82.3 (12.9) | 82.2 (14.7) | .924 | 92.3 (14.0) | <.001 | 90.9 (16.2) | <.001 |
BMI, kg/m2 | 27.2 (3.7) | 27.7 (3.8) | .039 | 29.9 (3.9) | <.001 | 30.3 (4.4) | <.001 |
Estimated % body fat | 27.4 (5.1) | 28.0 (5.5) | .049 | 30.7 (4.2) | <.001 | 30.3 (5.3) | <.001 |
Mid-upper arm circumference (cm) | 31.6 (3.1) | 31.3 (3.5) | .108 | 33.8 (3.8) | <.001 | 33.6 (3.8) | <.001 |
Having MetS, % | 29.3 | 44.6 | <.001 | 63.2 | <.001 | 62.5 | <.001 |
Bone ultrasound measurements | |||||||
Speed of sound, m/sec | 1552 (32) | 1542 (32) | <.001 | 1549 (27) | .395 | 1543 (30) | <.001 |
Broadband ultrasound attenuation, dB/MHz | 80.7 (17.9) | 74.9 (19.9) | <.001 | 81.1 (16.0) | .855 | 77.0 (18.0) | .001 |
Quantitative ultrasound index | 98.4 (20.0) | 91.8 (20.6) | <.001 | 97.3 (16.7) | .605 | 93.3 (19.1) | <.001 |
Estimated heel bone mineral density, g/cm2 | 0.55 (0.13) | 0.50 (0.13) | <.001 | 0.54 (0.11) | .623 | 0.51 (0.12) | <.001 |
. | Normal TT . | Normal TT . | P Value . | Low TT . | P Value . | Low TT . | P Value . |
---|---|---|---|---|---|---|---|
Normal cFT . | Low cFT . | Normal cFT . | Low cFT . | ||||
N, % 2641 (79.2%) | 277 (8.3%) | 96 (2.9%) | 320 (9.6%) | ||||
General | |||||||
Age, y | 58.9 (10.7) | 68.4 (9.3) | <.001 | 54.7 (9.2) | <.001 | 63.4 (10.8) | <.001 |
Current smoking, % | 21.7 | 19.3 | .358 | 16.8 | .263 | 18.6 | .211 |
Alcohol (≥5 days/week), % | 23.0 | 22.2 | .760 | 24.0 | .834 | 20.8 | .373 |
Fair or poor general health, % | 30.3 | 50.6 | <.001 | 28.4 | .696 | 44.6 | <.001 |
≥1 comorbidity, % | 60.3 | 79.9 | <.001 | 63.5 | .520 | 80.4 | <.001 |
Hormonal measurements | |||||||
Total T, nmol/liter | 18.4 (5.5) | 14.2 (3.7) | <.001 | 9.6 (0.7) | <.001 | 7.8 (2.5) | <.001 |
Calculated free T, pmol/liter | 325.7 (74.2) | 194.3 (22.7) | <.001 | 246.8 (19.5) | <.001 | 159.8 (55.3) | <.001 |
Total estradiol, pmol/liter | 76.7 (23.6) | 70.1 (25.7) | <.001 | 58.9 (17.6) | <.001 | 54.8 (19.6) | <.001 |
Free estradiol, pmol/liter | 1.3 (0.4) | 1.0 (0.4) | <.001 | 1.2 (0.4) | .040 | 1.0 (0.4) | <.001 |
SHBG, nmol/liter | 43.2 (17.2) | 58.1 (21.9) | <.001 | 18.9 (4.2) | <.001 | 31.6 (15.0) | <.001 |
LH, U/liter | 5.9 (3.0) | 8.8 (6.8) | <.001 | 4.8 (2.2) | .006 | 6.9 (6.8) | <.001 |
TSH, U/liter | 1.7 (1.2) | 1.6 (1.2) | .680 | 1.7 (1.8) | .523 | 1.8 (1.7) | .050 |
Free T4, ng/dL | 1.26 (0.22) | 1.27 (0.23) | .403 | 1.24 (0.24) | .550 | 1.23 (0.24) | .030 |
IGF-1, ng/mL | 134.5 (42.3) | 116.5 (43.3) | <.001 | 152.9 (47.2) | <.001 | 128.3 (57.0) | .015 |
Sexual function | |||||||
Overall sexual function score | 21.8 (6.8) | 17.6 (7.2) | <.001 | 23.1 (5.4) | .087 | 18.9 (7.5) | <.001 |
% men infrequent sexual thoughts | 25.1 | 42.3 | <.001 | 16.1 | .052 | 39.7 | <.001 |
% men erectile dysfunction | 27.0 | 51.0 | <.001 | 18.1 | .059 | 45.2 | <.001 |
% men infrequent morning erections | 35.5 | 64.1 | <.001 | 35.9 | .934 | 51.7 | <.001 |
% men with 3 sexual symptoms | 9.3 | 25.9 | <.001 | 5.5 | .220 | 23.5 | <.001 |
Physical function | |||||||
Time to walk 50 feet, sec | 13.4 (3.2) | 25.0 (5.0) | <.001 | 13.2 (2.6) | .581 | 14.4 (3.3) | <.001 |
SF36 physical function score | 50.7 (7.7) | 46.2 (9.6) | <.001 | 50.9 (7.9) | .845 | 47.6 (8.9) | <.001 |
% men reduced vigorous activity | 21.9 | 41.7 | <.001 | 19.2 | .529 | 38.6 | <.001 |
% men impairment in walking 1 km | 2.5 | 7.0 | <.001 | 3.2 | .678 | 7.0 | <.001 |
% men impairment in bending | 5.2 | 13.8 | <.001 | 2.1 | .199 | 12.0 | <.001 |
Psychological function | |||||||
Beck depression inventory score | 6.7 (6.4) | 8.1 (7.0) | .001 | 6.0 (5.7) | .262 | 7.8 (6.7) | .005 |
% men with sadness | 4.0 | 5.4 | .238 | 3.2 | .697 | 6.0 | .083 |
% men with loss of energy | 5.3 | 9.5 | .005 | 0 | 7.9 | .059 | |
% men with fatigue | 4.9 | 8.7 | .009 | 4.2 | .747 | 9.2 | .002 |
Biochemical measurements | |||||||
Hemoglobin, g/liter | 150.1 (10.7) | 146.4 (10.9) | <.001 | 148.7 (9.4) | .243 | 146.2 (13.0) | <.001 |
hs-CRP, mg/liter | 0.39 (0.66) | 0.61 (1.11) | <.001 | 0.63 (0.94) | .016 | 0.77 (1.52) | <.001 |
Glucose, mmol/liter | 5.5 (1.2) | 6.0 (2.0) | <.001 | 6.0 (1.6) | <.001 | 6.2 (2.0) | <.001 |
HOMA-IR | 2.9 (3.4) | 4.3 (6.1) | <.001 | 4.4 (3.3) | <.001 | 5.5 (6.7) | <.001 |
Body composition parameters | |||||||
Waist circumference, cm | 97.1 (10.4) | 99.9 (11.7) | <.001 | 105.4 (9.5) | <.001 | 106.5 (12.1) | <.001 |
Weight, kg | 82.3 (12.9) | 82.2 (14.7) | .924 | 92.3 (14.0) | <.001 | 90.9 (16.2) | <.001 |
BMI, kg/m2 | 27.2 (3.7) | 27.7 (3.8) | .039 | 29.9 (3.9) | <.001 | 30.3 (4.4) | <.001 |
Estimated % body fat | 27.4 (5.1) | 28.0 (5.5) | .049 | 30.7 (4.2) | <.001 | 30.3 (5.3) | <.001 |
Mid-upper arm circumference (cm) | 31.6 (3.1) | 31.3 (3.5) | .108 | 33.8 (3.8) | <.001 | 33.6 (3.8) | <.001 |
Having MetS, % | 29.3 | 44.6 | <.001 | 63.2 | <.001 | 62.5 | <.001 |
Bone ultrasound measurements | |||||||
Speed of sound, m/sec | 1552 (32) | 1542 (32) | <.001 | 1549 (27) | .395 | 1543 (30) | <.001 |
Broadband ultrasound attenuation, dB/MHz | 80.7 (17.9) | 74.9 (19.9) | <.001 | 81.1 (16.0) | .855 | 77.0 (18.0) | .001 |
Quantitative ultrasound index | 98.4 (20.0) | 91.8 (20.6) | <.001 | 97.3 (16.7) | .605 | 93.3 (19.1) | <.001 |
Estimated heel bone mineral density, g/cm2 | 0.55 (0.13) | 0.50 (0.13) | <.001 | 0.54 (0.11) | .623 | 0.51 (0.12) | <.001 |
Continuous variables are expressed as mean (standard deviation), categorical variables as percentages. P value for unadjusted linear (continuous variables) and logistic (categorical variables) regression, with normal TT/normal cFT as the referent group.
TSH, thyroid stimulating hormone; free T4, free thyroxin; HOMA-IR: homeostasis model assessment of insulin resistance.
. | Normal TT . | Normal TT . | P Value . | Low TT . | P Value . | Low TT . | P Value . |
---|---|---|---|---|---|---|---|
Normal cFT . | Low cFT . | Normal cFT . | Low cFT . | ||||
N, % 2641 (79.2%) | 277 (8.3%) | 96 (2.9%) | 320 (9.6%) | ||||
General | |||||||
Age, y | 58.9 (10.7) | 68.4 (9.3) | <.001 | 54.7 (9.2) | <.001 | 63.4 (10.8) | <.001 |
Current smoking, % | 21.7 | 19.3 | .358 | 16.8 | .263 | 18.6 | .211 |
Alcohol (≥5 days/week), % | 23.0 | 22.2 | .760 | 24.0 | .834 | 20.8 | .373 |
Fair or poor general health, % | 30.3 | 50.6 | <.001 | 28.4 | .696 | 44.6 | <.001 |
≥1 comorbidity, % | 60.3 | 79.9 | <.001 | 63.5 | .520 | 80.4 | <.001 |
Hormonal measurements | |||||||
Total T, nmol/liter | 18.4 (5.5) | 14.2 (3.7) | <.001 | 9.6 (0.7) | <.001 | 7.8 (2.5) | <.001 |
Calculated free T, pmol/liter | 325.7 (74.2) | 194.3 (22.7) | <.001 | 246.8 (19.5) | <.001 | 159.8 (55.3) | <.001 |
Total estradiol, pmol/liter | 76.7 (23.6) | 70.1 (25.7) | <.001 | 58.9 (17.6) | <.001 | 54.8 (19.6) | <.001 |
Free estradiol, pmol/liter | 1.3 (0.4) | 1.0 (0.4) | <.001 | 1.2 (0.4) | .040 | 1.0 (0.4) | <.001 |
SHBG, nmol/liter | 43.2 (17.2) | 58.1 (21.9) | <.001 | 18.9 (4.2) | <.001 | 31.6 (15.0) | <.001 |
LH, U/liter | 5.9 (3.0) | 8.8 (6.8) | <.001 | 4.8 (2.2) | .006 | 6.9 (6.8) | <.001 |
TSH, U/liter | 1.7 (1.2) | 1.6 (1.2) | .680 | 1.7 (1.8) | .523 | 1.8 (1.7) | .050 |
Free T4, ng/dL | 1.26 (0.22) | 1.27 (0.23) | .403 | 1.24 (0.24) | .550 | 1.23 (0.24) | .030 |
IGF-1, ng/mL | 134.5 (42.3) | 116.5 (43.3) | <.001 | 152.9 (47.2) | <.001 | 128.3 (57.0) | .015 |
Sexual function | |||||||
Overall sexual function score | 21.8 (6.8) | 17.6 (7.2) | <.001 | 23.1 (5.4) | .087 | 18.9 (7.5) | <.001 |
% men infrequent sexual thoughts | 25.1 | 42.3 | <.001 | 16.1 | .052 | 39.7 | <.001 |
% men erectile dysfunction | 27.0 | 51.0 | <.001 | 18.1 | .059 | 45.2 | <.001 |
% men infrequent morning erections | 35.5 | 64.1 | <.001 | 35.9 | .934 | 51.7 | <.001 |
% men with 3 sexual symptoms | 9.3 | 25.9 | <.001 | 5.5 | .220 | 23.5 | <.001 |
Physical function | |||||||
Time to walk 50 feet, sec | 13.4 (3.2) | 25.0 (5.0) | <.001 | 13.2 (2.6) | .581 | 14.4 (3.3) | <.001 |
SF36 physical function score | 50.7 (7.7) | 46.2 (9.6) | <.001 | 50.9 (7.9) | .845 | 47.6 (8.9) | <.001 |
% men reduced vigorous activity | 21.9 | 41.7 | <.001 | 19.2 | .529 | 38.6 | <.001 |
% men impairment in walking 1 km | 2.5 | 7.0 | <.001 | 3.2 | .678 | 7.0 | <.001 |
% men impairment in bending | 5.2 | 13.8 | <.001 | 2.1 | .199 | 12.0 | <.001 |
Psychological function | |||||||
Beck depression inventory score | 6.7 (6.4) | 8.1 (7.0) | .001 | 6.0 (5.7) | .262 | 7.8 (6.7) | .005 |
% men with sadness | 4.0 | 5.4 | .238 | 3.2 | .697 | 6.0 | .083 |
% men with loss of energy | 5.3 | 9.5 | .005 | 0 | 7.9 | .059 | |
% men with fatigue | 4.9 | 8.7 | .009 | 4.2 | .747 | 9.2 | .002 |
Biochemical measurements | |||||||
Hemoglobin, g/liter | 150.1 (10.7) | 146.4 (10.9) | <.001 | 148.7 (9.4) | .243 | 146.2 (13.0) | <.001 |
hs-CRP, mg/liter | 0.39 (0.66) | 0.61 (1.11) | <.001 | 0.63 (0.94) | .016 | 0.77 (1.52) | <.001 |
Glucose, mmol/liter | 5.5 (1.2) | 6.0 (2.0) | <.001 | 6.0 (1.6) | <.001 | 6.2 (2.0) | <.001 |
HOMA-IR | 2.9 (3.4) | 4.3 (6.1) | <.001 | 4.4 (3.3) | <.001 | 5.5 (6.7) | <.001 |
Body composition parameters | |||||||
Waist circumference, cm | 97.1 (10.4) | 99.9 (11.7) | <.001 | 105.4 (9.5) | <.001 | 106.5 (12.1) | <.001 |
Weight, kg | 82.3 (12.9) | 82.2 (14.7) | .924 | 92.3 (14.0) | <.001 | 90.9 (16.2) | <.001 |
BMI, kg/m2 | 27.2 (3.7) | 27.7 (3.8) | .039 | 29.9 (3.9) | <.001 | 30.3 (4.4) | <.001 |
Estimated % body fat | 27.4 (5.1) | 28.0 (5.5) | .049 | 30.7 (4.2) | <.001 | 30.3 (5.3) | <.001 |
Mid-upper arm circumference (cm) | 31.6 (3.1) | 31.3 (3.5) | .108 | 33.8 (3.8) | <.001 | 33.6 (3.8) | <.001 |
Having MetS, % | 29.3 | 44.6 | <.001 | 63.2 | <.001 | 62.5 | <.001 |
Bone ultrasound measurements | |||||||
Speed of sound, m/sec | 1552 (32) | 1542 (32) | <.001 | 1549 (27) | .395 | 1543 (30) | <.001 |
Broadband ultrasound attenuation, dB/MHz | 80.7 (17.9) | 74.9 (19.9) | <.001 | 81.1 (16.0) | .855 | 77.0 (18.0) | .001 |
Quantitative ultrasound index | 98.4 (20.0) | 91.8 (20.6) | <.001 | 97.3 (16.7) | .605 | 93.3 (19.1) | <.001 |
Estimated heel bone mineral density, g/cm2 | 0.55 (0.13) | 0.50 (0.13) | <.001 | 0.54 (0.11) | .623 | 0.51 (0.12) | <.001 |
. | Normal TT . | Normal TT . | P Value . | Low TT . | P Value . | Low TT . | P Value . |
---|---|---|---|---|---|---|---|
Normal cFT . | Low cFT . | Normal cFT . | Low cFT . | ||||
N, % 2641 (79.2%) | 277 (8.3%) | 96 (2.9%) | 320 (9.6%) | ||||
General | |||||||
Age, y | 58.9 (10.7) | 68.4 (9.3) | <.001 | 54.7 (9.2) | <.001 | 63.4 (10.8) | <.001 |
Current smoking, % | 21.7 | 19.3 | .358 | 16.8 | .263 | 18.6 | .211 |
Alcohol (≥5 days/week), % | 23.0 | 22.2 | .760 | 24.0 | .834 | 20.8 | .373 |
Fair or poor general health, % | 30.3 | 50.6 | <.001 | 28.4 | .696 | 44.6 | <.001 |
≥1 comorbidity, % | 60.3 | 79.9 | <.001 | 63.5 | .520 | 80.4 | <.001 |
Hormonal measurements | |||||||
Total T, nmol/liter | 18.4 (5.5) | 14.2 (3.7) | <.001 | 9.6 (0.7) | <.001 | 7.8 (2.5) | <.001 |
Calculated free T, pmol/liter | 325.7 (74.2) | 194.3 (22.7) | <.001 | 246.8 (19.5) | <.001 | 159.8 (55.3) | <.001 |
Total estradiol, pmol/liter | 76.7 (23.6) | 70.1 (25.7) | <.001 | 58.9 (17.6) | <.001 | 54.8 (19.6) | <.001 |
Free estradiol, pmol/liter | 1.3 (0.4) | 1.0 (0.4) | <.001 | 1.2 (0.4) | .040 | 1.0 (0.4) | <.001 |
SHBG, nmol/liter | 43.2 (17.2) | 58.1 (21.9) | <.001 | 18.9 (4.2) | <.001 | 31.6 (15.0) | <.001 |
LH, U/liter | 5.9 (3.0) | 8.8 (6.8) | <.001 | 4.8 (2.2) | .006 | 6.9 (6.8) | <.001 |
TSH, U/liter | 1.7 (1.2) | 1.6 (1.2) | .680 | 1.7 (1.8) | .523 | 1.8 (1.7) | .050 |
Free T4, ng/dL | 1.26 (0.22) | 1.27 (0.23) | .403 | 1.24 (0.24) | .550 | 1.23 (0.24) | .030 |
IGF-1, ng/mL | 134.5 (42.3) | 116.5 (43.3) | <.001 | 152.9 (47.2) | <.001 | 128.3 (57.0) | .015 |
Sexual function | |||||||
Overall sexual function score | 21.8 (6.8) | 17.6 (7.2) | <.001 | 23.1 (5.4) | .087 | 18.9 (7.5) | <.001 |
% men infrequent sexual thoughts | 25.1 | 42.3 | <.001 | 16.1 | .052 | 39.7 | <.001 |
% men erectile dysfunction | 27.0 | 51.0 | <.001 | 18.1 | .059 | 45.2 | <.001 |
% men infrequent morning erections | 35.5 | 64.1 | <.001 | 35.9 | .934 | 51.7 | <.001 |
% men with 3 sexual symptoms | 9.3 | 25.9 | <.001 | 5.5 | .220 | 23.5 | <.001 |
Physical function | |||||||
Time to walk 50 feet, sec | 13.4 (3.2) | 25.0 (5.0) | <.001 | 13.2 (2.6) | .581 | 14.4 (3.3) | <.001 |
SF36 physical function score | 50.7 (7.7) | 46.2 (9.6) | <.001 | 50.9 (7.9) | .845 | 47.6 (8.9) | <.001 |
% men reduced vigorous activity | 21.9 | 41.7 | <.001 | 19.2 | .529 | 38.6 | <.001 |
% men impairment in walking 1 km | 2.5 | 7.0 | <.001 | 3.2 | .678 | 7.0 | <.001 |
% men impairment in bending | 5.2 | 13.8 | <.001 | 2.1 | .199 | 12.0 | <.001 |
Psychological function | |||||||
Beck depression inventory score | 6.7 (6.4) | 8.1 (7.0) | .001 | 6.0 (5.7) | .262 | 7.8 (6.7) | .005 |
% men with sadness | 4.0 | 5.4 | .238 | 3.2 | .697 | 6.0 | .083 |
% men with loss of energy | 5.3 | 9.5 | .005 | 0 | 7.9 | .059 | |
% men with fatigue | 4.9 | 8.7 | .009 | 4.2 | .747 | 9.2 | .002 |
Biochemical measurements | |||||||
Hemoglobin, g/liter | 150.1 (10.7) | 146.4 (10.9) | <.001 | 148.7 (9.4) | .243 | 146.2 (13.0) | <.001 |
hs-CRP, mg/liter | 0.39 (0.66) | 0.61 (1.11) | <.001 | 0.63 (0.94) | .016 | 0.77 (1.52) | <.001 |
Glucose, mmol/liter | 5.5 (1.2) | 6.0 (2.0) | <.001 | 6.0 (1.6) | <.001 | 6.2 (2.0) | <.001 |
HOMA-IR | 2.9 (3.4) | 4.3 (6.1) | <.001 | 4.4 (3.3) | <.001 | 5.5 (6.7) | <.001 |
Body composition parameters | |||||||
Waist circumference, cm | 97.1 (10.4) | 99.9 (11.7) | <.001 | 105.4 (9.5) | <.001 | 106.5 (12.1) | <.001 |
Weight, kg | 82.3 (12.9) | 82.2 (14.7) | .924 | 92.3 (14.0) | <.001 | 90.9 (16.2) | <.001 |
BMI, kg/m2 | 27.2 (3.7) | 27.7 (3.8) | .039 | 29.9 (3.9) | <.001 | 30.3 (4.4) | <.001 |
Estimated % body fat | 27.4 (5.1) | 28.0 (5.5) | .049 | 30.7 (4.2) | <.001 | 30.3 (5.3) | <.001 |
Mid-upper arm circumference (cm) | 31.6 (3.1) | 31.3 (3.5) | .108 | 33.8 (3.8) | <.001 | 33.6 (3.8) | <.001 |
Having MetS, % | 29.3 | 44.6 | <.001 | 63.2 | <.001 | 62.5 | <.001 |
Bone ultrasound measurements | |||||||
Speed of sound, m/sec | 1552 (32) | 1542 (32) | <.001 | 1549 (27) | .395 | 1543 (30) | <.001 |
Broadband ultrasound attenuation, dB/MHz | 80.7 (17.9) | 74.9 (19.9) | <.001 | 81.1 (16.0) | .855 | 77.0 (18.0) | .001 |
Quantitative ultrasound index | 98.4 (20.0) | 91.8 (20.6) | <.001 | 97.3 (16.7) | .605 | 93.3 (19.1) | <.001 |
Estimated heel bone mineral density, g/cm2 | 0.55 (0.13) | 0.50 (0.13) | <.001 | 0.54 (0.11) | .623 | 0.51 (0.12) | <.001 |
Continuous variables are expressed as mean (standard deviation), categorical variables as percentages. P value for unadjusted linear (continuous variables) and logistic (categorical variables) regression, with normal TT/normal cFT as the referent group.
TSH, thyroid stimulating hormone; free T4, free thyroxin; HOMA-IR: homeostasis model assessment of insulin resistance.
This PDF is available to Subscribers Only
View Article Abstract & Purchase OptionsFor full access to this pdf, sign in to an existing account, or purchase an annual subscription.